Aligos Therapeutics Inc.

08/03/2023 | Press release | Archived content

Form 10-Q (0000950170 23 038045)

Aligos Therapeutics Inc. published this content on August 03, 2023, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 12, 2026 at 19:27 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]